HIV Pre-exposure Prophylaxis (PrEP) in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-effectiveness

BACKGROUND: The combination of tenofovir and emtricitabine (TDF/FTC) shows promise as HIV pre-exposure prophylaxis (PrEP). We sought to forecast clinical, epidemiologic, and economic outcomes of PrEP, taking into account uncertainties regarding efficacy, risk of resistance and toxicity, behavioral d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Paltiel, A. David, Freedberg, Kenneth A., Scott, Callie A., Schackman, Bruce R., Losina, Elena, Wang, Bingxia, Seage, George R., Sloan, Caroline E., Sax, Paul E., Walensky, Rochelle P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2876329/
https://ncbi.nlm.nih.gov/pubmed/19193111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/597095
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge